Search clinical trials for: GTX-101
Total 7431 results
-
Acasti Pharma Inc.Active, not recruitingAtaxia TelangiectasiaCanada
-
Amicus TherapeuticsActive, not recruiting
-
Sun Pharmaceutical Industries LimitedCompletedAn Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis SiccaKeratoconjunctivitis Sicca
-
Cryonove PharmaCEISO; Dermatech; Sefako Makgatho Health Sciences UniversityCompletedSolar Lentigo | Post-inflammatory Hyperpigmentation | Senile LentigoSouth Africa
-
Cryonove PharmaCEISO; Dermatech; LTD HEALTHCompleted
-
Transwell Biotech Co., Ltd.Completed
-
GTxCompletedProstate CancerUnited States
-
Kythera BiopharmaceuticalsBayerCompletedModerate or Severe Submental FullnessGermany, France, Belgium, Spain, United Kingdom
-
Kythera BiopharmaceuticalsCompletedPhase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)Moderate or Severe Submental FullnessUnited Kingdom, Canada, Australia
-
Neuraptive Therapeutics Inc.Active, not recruitingPeripheral Nerve InjuriesUnited States
-
Conjupro Biotherapeutics, Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingSolid TumorUnited States
-
Lytix Biopharma ASCompleted
-
Northwestern UniversityActive, not recruiting
-
GTxWithdrawnStress Urinary IncontinenceUnited States
-
GTxCompletedStress Urinary IncontinenceUnited States
-
Kythera BiopharmaceuticalsCompleted
-
Amytrx Therapeutics, Inc.Amarex Clinical ResearchCompletedAtopic DermatitisUnited States
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessAustralia, Canada, United Kingdom
-
Kythera BiopharmaceuticalsBayerCompletedModerate or Severe Submental FullnessBelgium, France, Germany, Italy, Spain, United Kingdom
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Amicus TherapeuticsActive, not recruitingBatten Disease | CLN6United States
-
GTxCompletedStress Urinary IncontinenceUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
TR TherapeuticsCompleted
-
Alaunos TherapeuticsCompleted
-
Alaunos TherapeuticsCompletedLymphoma | Multiple Myeloma | Acute Leukemia | Chronic Myeloproliferative Disease | Chronic Lymphoproliferative Disease | Poor-risk Myelodysplasia (MDS)United States
-
Amicus TherapeuticsCompletedVariant Late-Infantile Neuronal Ceroid LipofuscinosisUnited States
-
Brigham and Women's HospitalRecruiting
-
Alaunos TherapeuticsCompleted
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
GTxCompletedNon-Small Cell Lung Cancer | Muscle WastingUnited States
-
Aclaris Therapeutics, Inc.CompletedSeborrheic Keratosis (SK)United States
-
Ralexar Therapeutics, Inc.CompletedAtopic Dermatitis | Eczema, AtopicUnited States
-
University of FloridaNovatekNot yet recruiting
-
Scioderm, Inc.Amicus TherapeuticsCompletedEpidermolysis BullosaUnited States
-
Pharma Holdings ASCTC Clinical Trial Consultants ABRecruiting
-
Abalonex, LLCNot yet recruitingTraumatic Brain Injury | Cerebral Edema
-
Flame BiosciencesCompletedHealthy SubjectsUnited States
-
Azure Biotech Inc.Not yet recruitingPostmenopausal Symptoms
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Gilead SciencesWithdrawn
-
GTxTerminatedProstate CancerUnited States
-
Acasti Pharma Inc.Active, not recruitingPostherpetic NeuralgiaCanada
-
BlueWillow BiologicsPorton Biopharma Ltd.Completed